Search Results 481-490 of 11998 for Lupus

1. Genomics Arrives at the Clinic

   Steroid dosage risks and benefits when managing lupus nephritis. AI and Digital Health. Researchers explore potential for AI to predict patients' pain ...

2. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

   Active autoimmune disease (e.g., rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosis) requiring active systemic treatment. Hypothyroidism ...

3. Alzheimer's disease - Diagnosis and treatment - Mayo Clinic

   Understand more about this brain disorder that's the most common cause of dementia. Also learn about new tests and medicines on the market.

4. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   PTT (Partial Thromboplastin Time) or aPTT (activated Partial Thromboplastin Time) >1.5x the ULN in the absence of a lupus anticoagulant; INR (International ...

5. Rheumatoid arthritis: Can it affect the lungs? - Mayo Clinic

   Although rheumatoid arthritis primarily affects joints, it sometimes also causes lung disease. Occasionally, lung problems surface before the joint ...

6. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

   Note: Overlap with features of SSc, systemic lupus erythematosus, Sjogren's syndrome, or rheumatoid arthritis is allowed if the dominant clinical disease is DM.

7. A Study of the Effects of Aliskiren in Patients with Idiopathic Membranous Nephropathy - Mayo Clinic

   Presence of active infection or a secondary cause of MN (e.g. hepatitis B, HIV, systemic lupus erythematosus (SLE), medications, malignancies). Type 1 or 2 ...

8. Chronic lymphocytic leukemia - Symptoms and causes - Mayo Clinic

   Learn about this cancer that forms in white blood cells called lymphocytes. Treatments include chemotherapy, targeted therapy and immunotherapy.

9. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

   ... lupus erythematosus)requiring systemic immunosuppressive or system disease modifying agents within the last 2 years - Medical condition requiring prolonged ...

10. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    ... lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients ...